Navigation Links
Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
Date:2/6/2008

BIRMINGHAM, Ala., Feb. 6 /PRNewswire-FirstCall/ -- Emageon Inc. (Nasdaq: EMAG), a leader in enterprise medical information technology systems for hospitals, healthcare networks and imaging facilities, will hold its quarterly conference call to discuss fourth quarter and full year 2007 financial results on Thursday, February 21, 2008 at 8:30 AM Eastern Time. The company anticipates that these results will be available via a press release after the close of the NASDAQ stock market on Wednesday, February 20, 2008. In addition to releasing the fourth quarter and full year financial results, the company will also discuss financial guidance for 2008 during this conference call.

This call is being webcast by Thomson/CCBN and can be accessed at Emageon's Web site at http://investor.emageon.com . The dial-in telephone number for the call is 888.679.8033 (internationally, at 617.213.4846), passcode 49008180. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=P7J3XRTC7 . Pre-registrants will be issued a pin number to use when dialing into the live call that will provide quick access to the conference by bypassing the operator upon connection. A replay will be available from Thursday February 21, 2008 at 10:30 AM Eastern Time until 11:59 P.M. Eastern Time, March 02, 2008 at 888-286-8010 (internationally, at 617-801-6888), passcode 11893635.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the webcast at

SOURCE Emageon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
2. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
3. Emageon Names Chris E. Perkins as Chief Operating Officer
4. Emageon Reports Third Quarter 2007 Financial Results
5. HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call
6. HMS Holdings Corp. Hosts Fourth Quarter and Full Year 2007 Financial Teleconference and Presentation
7. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
8. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
9. Edwards Lifesciences Reports Strong Fourth Quarter Sales
10. Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007
11. Genomic Health Announces Fourth Quarter and Year-End 2007 Financial Results and Business Progress and 2008 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Trusted life science softwar...ment clients to engage via GSA. , ... Solutions, an emerging software engineering firm...rd of a U.S. General Services Administration (GSA)...ent customers with the ability to conveniently eng...
(Date:8/28/2008)...tion improved even after conventional therapy, stu...y News) -- Working out on a treadmill improves bra...ed a stroke and gone through the usual rehabilitat...two problems these patients have," said study rese...eurology and neurorehabilitation at the University...
(Date:8/28/2008)...MOUNTAIN VIEW, Calif., Aug. 28 /PRNewswire/ -- The...e Year Award is presented to Redsense,Medical in r...blood loss,detecting device. "Redsense detects the...e lives of many patients"., The device consists o...cted to the alarm using fibre optic technology tha...
(Date:8/28/2008)...IRVINE, Calif., Aug. 28 /PRNewswire-FirstCall/ -- ... announced it will present at the Thomas Weisel,Pa... Time on Thursday,September 4, 2008 at the Four S... Chief Executive Officer, Vicente Anido, Jr.,Ph.D...ial and clinical,progress. To access the live audi...
Breaking Medicine News(10 mins):Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3
...ifferences in normal peoples sleep. Some are light...asleep right away, while others take their time . ...attributed solely to differences in circumstances,...ctors. But now a study led by Hans Van Dongen, ass...
...procedures among most notable increases. Approxima...ormed worldwide in 2006, up 34 percent from 2004, ...ent member survey conducted by the International S... world's leading medical authority on hair loss an...
...ool of Medicine in St. Louis have just given peopl...at smoking interferes with ligament healing. The r...found that cigarette smoking impairs the recruitme...lays healing following ligament repair surgery. ...
...ngham (UAB) have traced the differences and simila...nd that in human RNA , a significant development t...biotic resistance. The new findings have been rep...thored by Dr. Dmitry Vassylyev, Professor of Bioch...
Other Medicine News:Health News:Individual Differences in Sleep Structure are Biologically Determined 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 3Health News:Smoking Hampers Healing of the Ligament 2Health News:Scientists Trace New Pathway That may Stem Antibiotic Resistance 2
(Date:8/27/2008)...cognized Pediatric Heart Center at The Children,s ...unity to Complete Range of Care and ...Pediatric Cardiology Team Treats Every Heart Condi...- The Children,s Hospital at,Montefiore (CHAM) is ...ansplantation to the Bronx, following the recent a...
(Date:8/26/2008)...IS, Aug. 26 /- Semafore Pharmaceutica...l Congress on Targeted Therapies,in Cancer in Wash...lti-targeted kinase inhibitors that demonstrate si...es., A novel and proprietary molecular scaffold h...owing for the design of pan-PI3 kinase inhibitors,...
(Date:8/26/2008)... - Coupled with Innovative Manufacturing - Has Pot...emic Preparedness, ROCKVILLE, Md., Aug. 26 /PRNew... announced today favorable results from the second...its pandemic influenza virus-like,particle (VLP) v...ain an,adjuvant, induced robust neutralizing antib...
(Date:8/25/2008)... Patient calls it a ,miracle, LATHAM, N...from the,Image Guided Radiation Therapy program at...d treating cancer patients using RapidArc(TM),radi...YSE: VAR ), an,advancement that delivers a highly...erapy (IMRT) treatment in two minutes or less., R...
Breaking Medicine Technology:Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection 1783 1NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection 1783 2Preclinical Study Shows CTIs Brostallicins Cancer Killing Ability Based on Genetic Profiling 1781 1Preclinical Study Shows CTIs Brostallicins Cancer Killing Ability Based on Genetic Profiling 1781 2Preclinical Study Shows CTIs Brostallicins Cancer Killing Ability Based on Genetic Profiling 1781 3Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 1Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 2Neurotechnologija Changes Corporate Name to Neurotechnology 2890 1Neurotechnologija Changes Corporate Name to Neurotechnology 2890 2
...eir Own Household, SWIFTWATER, Pa., March 27, 2007... April issue of The Pediatric Infectious,Disease J...only,known as whooping cough -- found that househo... cases among infants for whom a,source case could ...tance of vaccination of close contacts of infants ...
... in Valortim-Treated Animals, , PRINCETON, N.J. an...Call/ -- Medarex, Inc. , a leading monoclonal,anti...eld,biotechnology company dedicated to the develop...d that Valortim(TM), a fully human,monoclonal anti...vention and treatment of anthrax infection, has be...
Other Medicine Technology:New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 2New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 3New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 4New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 5New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 8
Flexible vinyl with a rigid bite block. Guedel-style with three internal channels. Individually packaged, 48 per case. Latex Free.
Includes one of each size airway. Plastic. Color coded for size. Single use. Non-Sterile.
Our soft guedel airway is clear and has a color coded bite block. Airway has a smooth finish and is Latex Free. Recommended for single use. Non-Sterile.
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex
Medicine Products: